Cargando…

Lipid metabolism in cancer progression and therapeutic strategies

Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy producers, signaling molecules, and source material for the biogenesis of cell membranes. The enhanced synthesis, st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Yan, Zou, Tiantian, Shen, Xiaotian, Nelson, Peter J., Li, Jiahui, Wu, Chao, Yang, Jimeng, Zheng, Yan, Bruns, Christiane, Zhao, Yue, Qin, Lunxiu, Dong, Qiongzhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491217/ https://www.ncbi.nlm.nih.gov/pubmed/34766135 http://dx.doi.org/10.1002/mco2.27

Ejemplares similares

The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics
por: Shen, Xiaotian, et al.
Publicado: (2020)

Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer
por: Zheng, Yan, et al.
Publicado: (2020)

CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
por: Jia, Qingan, et al.
Publicado: (2015)

A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes
por: Hu, Beiyuan, et al.
Publicado: (2022)

An integrative strategy for quantitative analysis of the N-glycoproteome in complex biological samples
por: Wang, Ji, et al.
Publicado: (2014)

Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
por: Wang, Hao, et al.
Publicado: (2021)

Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3
por: Sun, Haoting, et al.
Publicado: (2021)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice
por: LI, GUOCAI, et al.
Publicado: (2013)

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
por: Wu, Xiaolin, et al.
Publicado: (2020)

Progress in therapeutic strategies based on cancer lipid metabolism
por: Diao, Xia‐Yao, et al.
Publicado: (2019)

Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
por: Wang, Zhefang, et al.
Publicado: (2020)

Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner
por: Qin, Zhaoyu, et al.
Publicado: (2019)

Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma
por: Wei, Jinwang, et al.
Publicado: (2019)

Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer
por: Wang, Zhefang, et al.
Publicado: (2020)

Current diagnostics and treatment of fibrosarcoma –perspectives for future therapeutic targets and strategies
por: Augsburger, Daniela, et al.
Publicado: (2017)

CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity
por: Fu, Yan, et al.
Publicado: (2022)

Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
por: Hu, Beiyuan, et al.
Publicado: (2022)

Editorial: Cancer Cell Metabolism and Immunomodulation in the Context of Tumor Metastasis
por: Dong, Qiongzhu, et al.
Publicado: (2022)

An Angiogenic Gene Signature for Prediction of the Prognosis and Therapeutic Responses of Hepatocellular Carcinoma
por: Ci, Hongfei, et al.
Publicado: (2023)

Characteristics of the cancer stem cell niche and therapeutic strategies
por: Ju, Feng, et al.
Publicado: (2022)

Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma
por: Zeng, Lingyao, et al.
Publicado: (2012)

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

CAV1 Promotes HCC Cell Progression and Metastasis through Wnt/β-Catenin Pathway
por: Yu, Hongxiu, et al.
Publicado: (2014)

The Diverse Mechanisms of miRNAs and lncRNAs in the Maintenance of Liver Cancer Stem Cells
por: Zhao, Jing, et al.
Publicado: (2018)

Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
por: Gao, Xiaomei, et al.
Publicado: (2018)

Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
por: Gao, Xiaomei, et al.
Publicado: (2023)

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer
por: Zhou, Chenghui, et al.
Publicado: (2020)

Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer
por: Zhao, Jiangang, et al.
Publicado: (2017)

miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma
por: Lian, Junwei, et al.
Publicado: (2015)

Surf4, cargo trafficking, lipid metabolism, and therapeutic implications
por: Shen, Yishi, et al.
Publicado: (2022)

Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies
por: Lin, Hanchao, et al.
Publicado: (2023)

The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies
por: Wang, Danting, et al.
Publicado: (2022)

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
por: Gaar-Humphreys, Karen R., et al.
Publicado: (2023)

Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
por: Siltari, Aino, et al.
Publicado: (2022)

Lipid Metabolism in the Development and Progression of Vascular Cognitive Impairment: A Systematic Review
por: Qin, Qi, et al.
Publicado: (2021)

Transcriptional Inhibition of AGPAT2 Induces Abnormal Lipid Metabolism and Oxidative Stress in the Liver of Nile Tilapia Oreochromis niloticus
por: Feng, Tiantian, et al.
Publicado: (2023)

Lipid metabolism in tumor microenvironment: novel therapeutic targets
por: Liu, Xingkai, et al.
Publicado: (2022)

Therapeutic Progress
por: Wilson, Nelson W.
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_1hpopnb08e3oipakl7t388ijak